Original Research

Accepted on 29 Nov 2024

First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study

in Thoracic Oncology

Aida Piedra
Sergio Martínez-Recio
Ainhoa Hernández
Teresa Moran
Edurne Arriola
Jordi Recuero-Borau
Manuel Cobo Dols
Patricia Cordeiro
Joaquín Mosquera
Manuel Fernández

Frontiers in Oncology

doi 10.3389/fonc.2024.1510278

Case Report

Published on 29 Nov 2024

Anesthetic management of acute right heart failure in patients with pulmonary embolism undergoing AngioJet pulmonary embolectomy: a case report

in Thoracic Oncology

Shasha Zhang
Fangeng Meng
Chao Zhou
Yiwen Zhang
Huaqin Liu
Yuanyuan Rong

Frontiers in Oncology

doi 10.3389/fonc.2024.1477922

206 views

Case Report

Published on 29 Nov 2024

Case report: A case of giant malignant solitary fibrous tumor of the pleura with Doege-Potter’s syndrome and review of the literature

in Thoracic Oncology

Jie Li
Hong-Tao Tang
Qing Liu
Cai-Han Li
Wei-Yang Chen
Zeng-Wei Yu
Lei Wang
Lin Lin
Jin-Lan Zhao
Chun-Yan Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1437535

130 views

Case Report

Accepted on 27 Nov 2024

Huge Extramedullary Hematopoiesis Mass in the Posterior Mediastinum: A Case Report

in Thoracic Oncology

Zhao Junjun
Dong Lingjun
Ma Zhifeng
Zhang Chu
Wang Haiyong

Frontiers in Oncology

doi 10.3389/fonc.2024.1489785

150 views

Original Research

Published on 27 Nov 2024

Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1

in Thoracic Oncology

Zachary D. Wallen
Mary K. Nesline
Marni Tierno
Alison Roos
Erica Schnettler
Hatim Husain
Pratheesh Sathyan
Brian Caveney
Marcia Eisenberg
Eric A. Severson

Frontiers in Oncology

doi 10.3389/fonc.2024.1473327

364 views

Original Research

Published on 26 Nov 2024

The diagnostic efficacy of seven autoantibodies in early detection of ground-glass nodular lung adenocarcinoma

in Thoracic Oncology

Hua Guo
Wei Zhao
Chunsun Li
Zhen Wu
Ling Yu
Miaoyu Wang
Yuanhui Wei
Zirui Wang
Shangshu Liu
Yue Yin

Frontiers in Oncology

doi 10.3389/fonc.2024.1499140

121 views

Case Report

Published on 26 Nov 2024

Exploring the multifaceted challenges of gastrointestinal metastases in lung adenocarcinoma: a case report highlighting diagnostic dilemmas and therapeutic innovations

in Thoracic Oncology

Xinxin Xu
Qian Zhou
Peng Chen
Chengzhou Du
Yonghua Huang
Xiaoxin Gao
Shumei Xu
Jinling Wu
Tianxiao He
Hongtao Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1486371

164 views

Original Research

Accepted on 25 Nov 2024

Descriptive Analysis of Durvalumab Use in Unresectable Stage III Non-Small Cell Lung Cancer in Patients Treated in Quebec's University Teaching Hospitals

in Thoracic Oncology

Valérie Labrie
Judith Lefebvre
Catherine Labbé
Kevin Jao
Mandy Malick
Serge Simard
Nicole Bouchard

Frontiers in Oncology

doi 10.3389/fonc.2024.1506172

Review

Accepted on 25 Nov 2024

Predicting Lymph Node Metastasis of Clinical T1 Non-small Cell Lung Cancer:a brief review of possible methodologies and controversies

in Thoracic Oncology

Li Zhang
Feiyue Zhang
Gaofeng Li
Xudong Xiang
Haifeng Liang
Yan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1422623

Case Report

Accepted on 25 Nov 2024

Newly emerged ROS1 rearrangement in a patient with lung adenocarcinoma following resistance to Immune Checkpoint Inhibitors: A case report

in Thoracic Oncology

Jian Wang
Bingyue Liu
Jianxin Chen
Ruoshui Xiao

Frontiers in Oncology

doi 10.3389/fonc.2024.1507658

Case Report

Accepted on 21 Nov 2024

Primary pulmonary hyalinizing clear cell carcinoma with EWSR1 gene translocation: a case report

in Thoracic Oncology

Canhui Jian
Shuai Luo
Jinjing Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1509132

Original Research

Accepted on 20 Nov 2024

Predicting epidermal growth factor receptor mutation status of lung adenocarcinoma based on PET/CT images using deep learning

in Thoracic Oncology

Lele Huang
Weifang Kong
Yongjun Luo
Hongjun Xie
Jiangyan Liu
Xin Zhang
Guojin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1458374

Original Research

Accepted on 20 Nov 2024

A novel interplay between bacteria and metabolites in different earlystage lung cancer: An integrated microbiome and metabolome analysis

in Thoracic Oncology

Xiaoqian Zhai
Dongqi Lin
Yi Shen
Fan Yu
Jiabi Zhang
Yiyun Lin
Qinghua Zhou
Xi Zheng

Frontiers in Oncology

doi 10.3389/fonc.2024.1492571

Review

Accepted on 20 Nov 2024

Biomarkers for Immunotherapy Resistance in Non-Small Cell Lung Cancer

in Thoracic Oncology

Catriona J Rother
Tom John
Annie Wong

Frontiers in Oncology

doi 10.3389/fonc.2024.1489977

Case Report

Published on 19 Nov 2024

Treatment of recurrent tracheal adenoid cystic carcinoma with a covered airway stent loaded with Iodine-125 seeds: a 5-year follow-up case report

in Thoracic Oncology

Zhen Yang
Yafei Wang
Zhenhua Li
Shuang Geng
Yi Hu

Frontiers in Oncology

doi 10.3389/fonc.2024.1450508

205 views

Case Report

Accepted on 18 Nov 2024

Long-term Follow-up of Combination Therapy with Pembrolizumab and Anlotinib in Thoracic SMARCA4-deficient Undifferentiated Tumor : A Case Report and Molecular Features

in Thoracic Oncology

Ting Duan
Mingxin Xu
Haibo Zhang
Shengchang Wu
Haochu Wang
Zhenying Guo

Frontiers in Oncology

doi 10.3389/fonc.2024.1453895

Navigation group

Articles

First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study

Anesthetic management of acute right heart failure in patients with pulmonary embolism undergoing AngioJet pulmonary embolectomy: a case report

Case report: A case of giant malignant solitary fibrous tumor of the pleura with Doege-Potter’s syndrome and review of the literature

Huge Extramedullary Hematopoiesis Mass in the Posterior Mediastinum: A Case Report

Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1

The diagnostic efficacy of seven autoantibodies in early detection of ground-glass nodular lung adenocarcinoma

Exploring the multifaceted challenges of gastrointestinal metastases in lung adenocarcinoma: a case report highlighting diagnostic dilemmas and therapeutic innovations

Descriptive Analysis of Durvalumab Use in Unresectable Stage III Non-Small Cell Lung Cancer in Patients Treated in Quebec's University Teaching Hospitals

Predicting Lymph Node Metastasis of Clinical T1 Non-small Cell Lung Cancer:a brief review of possible methodologies and controversies

Newly emerged ROS1 rearrangement in a patient with lung adenocarcinoma following resistance to Immune Checkpoint Inhibitors: A case report

Primary pulmonary hyalinizing clear cell carcinoma with EWSR1 gene translocation: a case report

Predicting epidermal growth factor receptor mutation status of lung adenocarcinoma based on PET/CT images using deep learning

A novel interplay between bacteria and metabolites in different earlystage lung cancer: An integrated microbiome and metabolome analysis

Biomarkers for Immunotherapy Resistance in Non-Small Cell Lung Cancer

Treatment of recurrent tracheal adenoid cystic carcinoma with a covered airway stent loaded with Iodine-125 seeds: a 5-year follow-up case report

Long-term Follow-up of Combination Therapy with Pembrolizumab and Anlotinib in Thoracic SMARCA4-deficient Undifferentiated Tumor : A Case Report and Molecular Features